NephroDI Therapeutics Announces Investment by Sound Bioventures to Accelerate Development of NDI-5001 as a Potential First-in-Class Therapy for Pediatric Orphan Kidney DiseaseYou must be logged in to view this page.
Sound Bioventures: Putting Scandinavian Biotechs on the Global StageYou must be logged in to view this page.
Earthquakes, investing in drugs, and how to be decent in Venture Capital.You must be logged in to view this page.
Sound Bioventures joins £19M ($24.5M) financing in UK oncolytic virus company TheolyticsYou must be logged in to view this page.
Beyond fundraising: how do venture capitals build early-stage biotechs?You must be logged in to view this page.
ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIa ArthemiR™ Trial of ATX-01 for Myotonic Dystrophy Type 1 (DM1)You must be logged in to view this page.
Artax Announces First Patient Dosed in Phase 2a Psoriasis Trial Evaluating AX-158.You must be logged in to view this page.
VC Investing in Clinical Stage Biotherapeutics Companies in Europe and the U.S.You must be logged in to view this page.
Breye Therapeutics Commences Oral Dosing of Danegaptide in Patients with Diabetic RetinopathyYou must be logged in to view this page.